Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 4/20 | 0.41 |
| ▸ | NOS1 | P29475 | 3/20 | 0.39 |
| ▸ | HTR2C | P28335 | 2/20 | 0.36 |
| ▸ | HTR2A | P28223 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.35 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.34 |
| ▸ | HPGD | P15428 | 2/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.34 |
| ▸ | MEN1 | O00255 | 2/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.34 |
| ▸ | PLK4 | O00444 | 1/20 | 0.34 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.34 |
| ▸ | AURKA | O14965 | 1/20 | 0.34 |
| ▸ | DAPK3 | O43293 | 1/20 | 0.34 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.34 |
| ▸ | CSF1R | P07333 | 1/20 | 0.34 |
| ▸ | RET | P07949 | 1/20 | 0.34 |
| ▸ | FGFR1 | P11362 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20866826 | 0.77 | ADRA2A (0.49) | MAPTNOS1LMNAADRA2AADRA2B | |
| SCHEMBL12469544 | 0.73 | MAPT (0.43) | MAPTNOS1KDM4EHPGDTDP1 | |
| SCHEMBL4913293 | 0.73 | DYRK1A (0.38) | MAPTNOS1HTR2CLMNATDP1 | |
| SCHEMBL6199102 | 0.71 | MAPT (0.39) | MAPTNOS1KDM4EHPGDTDP1 | |
| SCHEMBL6198760 | 0.70 | NOS1 (0.43) | MAPTNOS1KDM4EHPGDTDP1 | |
| SCHEMBL6194058 | 0.70 | NOS1 (0.43) | MAPTNOS1KDM4EHPGDTDP1 | |
| SCHEMBL6197375 | 0.70 | MAPT (0.45) | MAPTNOS1KDM4EHPGDTDP1 | |
| SCHEMBL17897161 | 0.69 | TNF (0.37) | MAPTHTR2CHTR2ALMNAADRA2A | |
| SCHEMBL276444 | 0.68 | HSD17B10 (0.53) | MAPTNOS1KDM4EHPGDTDP1 | |
| SCHEMBL10655958 | 0.68 | MAPT (0.46) | MAPTNOS1KDM4EHPGDTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 63 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2336315-B1 | Enzymatic encoding methods for efficient synthesis of large libraries | NUEVOLUTION AS (DK) | 2017-07-19 | — | — | EP | claimed |
| EP-2336315-A2 | Enzymatic encoding methods for efficient synthesis of large libraries | Nuevolution A/S (DK) | 2011-06-22 | — | — | EP | claimed |
| EP-3360578-B1 | COMPOSITE GRANULATED PRODUCT INCLUDING SUGAR OR SUGAR ALCOHOL, SWELLING BINDER, DISINTEGRATING AGENT AND HIGHLY ABSORBENT EXCIPIENT, AND METHOD FOR MANUFACTURING COMPOSITE GRANULATED PRODUCT | DAIDO CHEMICAL CORP (JP) | 2024-12-11 | — | — | EP | disclosed |
| US-11702652-B2 | Enzymatic encoding methods for efficient synthesis of large libraries | NUEVOLUTION A/S (DK) | 2023-07-18 | — | — | US | disclosed |
| EP-3238711-B1 | BASE FOR SOLID DISPERSION, PRODUCTION METHOD FOR SOLID DISPERSION USING SAME, AND SOLID DISPERSION | MITSUBISHI CHEM CORP (JP) | 2023-07-12 | — | — | EP | disclosed |
| US-20220340893-A1 | BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES | NUEVOLUTION A/S (DK) | 2022-10-27 | — | — | US | disclosed |
| US-11225655-B2 | Bi-functional complexes and methods for making and using such complexes | NUEVOLUTION A/S (DK) | 2022-01-18 | — | — | US | disclosed |
| EP-3305900-B1 | ENZYMATIC ENCODING METHODS FOR EFFICIENT SYNTHESIS OF LARGE LIBRARIES | NUEVOLUTION AS (DK) | 2021-07-21 | — | — | EP | disclosed |
| US-20200216836-A1 | ENZYMATIC ENCODING METHODS FOR EFFICIENT SYNTHESIS OF LARGE LIBRARIES | NUEVOLUTION A/S (DK) | 2020-07-09 | — | — | US | disclosed |
| US-10632074-B2 | Composite granulated product including sugar or sugar alcohol, swelling binder, disintegrating agent and highly absorbent excipient, and method for manufacturing composite granulated product | DAIDO CHEMICAL CORPORATION (JP) | 2020-04-28 | — | — | US | disclosed |
| CN-106232144-B | Solid dispersion | 武田药品工业株式会社 | 2019-12-06 | — | — | CN | disclosed |
| US-20080145431-A1 | Medicinal Composition and Process for Producing the Same | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2008-06-19 | — | — | US | disclosed |
| US-20080063710-A1 | Rapidly Disintegrating Tablet and Production Method Thereof | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2008-03-13 | — | — | US | disclosed |
| EP-1839650-A1 | QUICK DISINTEGRATION TABLET AND METHOD OF PRODUCING THE SAME | Eisai R&D Management Co., Ltd. (JP) | 2007-10-03 | — | — | EP | disclosed |
| EP-1834624-A1 | MEDICINAL COMPOSITION AND PROCESS FOR PRODUCING THE SAME | Eisai R&D Management Co., Ltd. (JP) | 2007-09-19 | — | — | EP | disclosed |
| WO-2007062664-A2 | ENZYMATIC ENCODING METHODS FOR EFFICIENT SYNTHESIS OF LARGE LIBRARIES | NUEVOLUTION A/S (DK) | 2007-06-07 | — | — | WO | disclosed |
| US-20060151899-A1 | Process for producing drug ultramicroparticle and apparatus therefor | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2006-07-13 | — | — | US | disclosed |
| EP-1652515-A1 | PROCESS FOR PRODUCING DRUG ULTRAMICROPARTICLE AND APPARATUS THEREFOR | Eisai Co., Ltd. (JP) | 2006-05-03 | — | — | EP | disclosed |
| US-20030185878-A1 | Process for producing phospholipid-containing drug | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2003-10-02 | — | — | US | disclosed |
| EP-1293197-A1 | PROCESS FOR PRODUCING PHOSPHOLIPID-CONTAINING DRUGS | Takeda Chemical Industries, Ltd. (JP) | 2003-03-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030185878-A1 | Process for producing phospholipid-containing drug | PHOSPHO1, PLTP, PTDSS2 | MAPT 1129/4885NOS1 1624/4885HTR2C 4060/4885 |
| US-10632074-B2 | Composite granulated product including sugar or sugar alcohol, swelling binder, disintegrating agent and highly absorbent excipient, and method for manufacturing composite granulated product | SORD, STT3B, DDOST | MAPT 1360/4885NOS1 2435/4885HTR2C 3204/4885 |
| US-20080145431-A1 | Medicinal Composition and Process for Producing the Same | RPLP2, MYD88, EIF4G2 | MAPT 802/4885NOS1 608/4885HTR2C 3139/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.